Home   >  

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

Protease/Metabolic Enzyme

Chemical Structure Cat. No. Product Name CAS No.
SGK1-IN-4 Chemical Structure
BCP46276 SGK1-IN-4 1628048-93-0
SGK1-IN-4 is a highly selective, orally active SGK1 inhibitor.
BI-6C9 Chemical Structure
BCP46234 BI-6C9 791835-21-7
BI-6C9 is an inhibitor of tBid (Kd = 20 µM).
Tecovirimat Chemical Structure
BCP46174 Tecovirimat 869572-92-9
Tecovirimat is an Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor. The mechanism of action of tecovirimat is as a Cytochrome P450 3A Inducer, and Cytochrome P450 2C8 Inhibitor, and Cytochrome P450 2C19 Inhibitor, and Breast Cancer Resistance Protein Inhibitor.
Upamostat Chemical Structure
BCP46045 Upamostat 1191101-18-4
Upamostat is an orally bioavailable, 3-amidinophenylalanine-derived, second generation serine protease inhibitor prodrug targeting the human urokinase plasminogen activator (uPA) system with potential antineoplastic and antimetastatic activities. After oral administration, serine protease inhibitor WX-671 is converted to the active Nα-(2,4,6-triisopropylphenylsulfonyl)-3-amidino-(L)-phenyla lanine-4-ethoxycarbonylpiperazide (WX-UK1), which inhibits several serine proteases, particularly uPA; inhibition of uPA may result in the inhibition of tumor growth and metastasis.
Mito-apocynin (C11) Chemical Structure
BCP46038 Mito-apocynin (C11) 1254044-38-6
Mito-apocynin (C11), an orally active mitochondria-targeted triphenylphosphonium (TPP)-based compound, is synthesized by conjugating the Apocynin moiety with a TPP+ cation.
HSP27 inhibitor J2 Chemical Structure
BCP46015 HSP27 inhibitor J2 2133499-85-9
HSP27 inhibitor J2 is a HSP27 inhibitor, inhibits a production of HSP27 giant polymers, thereby having an effect of inhibiting a chaperone function of the HSP27 and reducing a cell protection function.
Darexaban Chemical Structure
BCP45981 Darexaban 365462-23-3
Darexaban is a potent, selective and orally active factor Xa (FXa) inhibitor with an IC50 of 54.6 nM. Darexaban shows high selectivity against other related serine proteases, such as trypsin, thrombin, and kallikrein. Darexaban has anticoagulant and antithrombotic effects.
BAY 2666605 Chemical Structure
BCP45964 BAY 2666605 2275774-60-0
BAY 2666605 is an orally active PDE3A and PDE3B inhibitor with IC50s of 87 nM and 50 nM, respectively.
NPX800 Chemical Structure
BCP45963 NPX800 1693734-80-3
NPX-800 is a potent, selective, oral heat shock factor 1 (HSF1) pathway inhibitor.
ABBV-CLS-484 Chemical Structure
BCP45961 ABBV-CLS-484 2489404-97-7
ABBV-CLS-484 is a novel, orally bioavailable PTPN2 inhibitor for treatment of advanced or metastatic tumors.
123下一页末页共 1055 条记录 1 / 106 页 
0086-13720134139